Power and railway equipment producer Hind Rectifiers is expanding its manufacturing facilities in Nashik and has also decided ...

The company's Consumer Wellness business registered revenues of Rs. 448.8 crore, up 13 % y-o-y with 4.8% volume growth.

AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...

The Nifty Pharma index closed on a positive note on Friday. Shares of Dr. Reddy's Laboratories Ltd.(up 1.92 per cent), Zydus Lifesciences Ltd.(up 1.77 per cent), Biocon Ltd.(up 1.56 per cent), Cipla ...

AM(IST)on Friday in an upbeat market. Biocon Ltd.(up 1.88 per cent), Zydus Lifesciences Ltd.(up 1.29 per cent), Dr. Reddy's ...

Zydus Takeda Healthcare Private Limited, a joint venture between Zydus Lifesciences and Takeda Pharmaceutical, celebrates the ...

( MENAFN - IANS) New Delhi, Jan 26 (IANS) Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday thanked the government for ...

Pankaj Patel, Chairman of Zydus Lifesciences, has been awarded the prestigious Padma Bhushan for his contributions to the Indian lifesciences industry. Patel has steered Zydus towards innovation and ...

Chairman of Zydus Lifesciences, Pankaj Patel, on Sunday expressed his gratitude upon being bestowed with one of India's ...

Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.

Saroglitazar is under clinical development by Zydus Therapeutics and currently in Phase II for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to GlobalData, Phase II drugs for ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, order wins and acquisitions, here’s a quick look at which stocks will be ...